prostaglandin d2

Preferred Label : prostaglandin d2;

MeSH definition : The principal cyclooxygenase metabolite of arachidonic acid. It is released upon activation of mast cells and is also synthesized by alveolar macrophages. Among its many biological actions, the most important are its bronchoconstrictor, platelet-activating-factor-inhibitory, and cytotoxic effects.;

MeSH synonym : d2, prostaglandin; f2 alpha, 11-dehydroprostaglandin; f2alpha, 11-dehydroprostaglandin; pgd2; 11-dehydroprostaglandin f2 alpha; 11-dehydroprostaglandin f2alpha; 11 dehydroprostaglandin f2 alpha; alpha, 11-dehydroprostaglandin f2; 11 dehydroprostaglandin f2alpha;

MeSH CAS label : Prosta-5,13-dien-1-oic acid, 9,15-dihydroxy-11-oxo-, (5Z,9alpha,13E,15S)-;

MeSH Related Number : 41598-07-6 (Prostaglandin D2);

Registry Number MeSH : 41598-07-6;

MeSH annotation : /biosyn /physiol permitted; DF: PGD2;

Is substance : O;

UNII : RXY07S6CZ2;

Détails

Origin ID

D015230;

UMLS CUI

C0033532;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Prostaglandin D2 [NCIt concept]
- Prostaglandin D2 [LOINC component]
- Prostaglandin PGD2 (substance) [SNOMED CT concept]
Indexing information
- 10T024A compound [MeSH Supplementary Concept]
- prostaglandin D2 receptor [MeSH Supplementary Concept]
Record concept(s)
- prostaglandin D2 [MeSH concept]
Related MeSH Supplementary Concept(s)
- 11,15-dioxo-9-hydroxy-2,3,4,5-tetranorprostan-1,20-dioic acid [MeSH Supplementary Concept]
- 11-methoxime prostaglandin D2 [MeSH Supplementary Concept]
- 11-methyleneprostaglandin D2 [MeSH Supplementary Concept]
- 13,14-dihydro-15-ketoprostaglandin D2 [MeSH Supplementary Concept]
- 15-deoxy-9,10-dihydro-delta(12,14)-prostaglandin J2 [MeSH Supplementary Concept]
- 15-deoxy-delta(12,14)-prostaglandin J2 [MeSH Supplementary Concept]
- 15-deoxyprostaglandin J2 [MeSH Supplementary Concept]
- 15-methylprostaglandin D2 [MeSH Supplementary Concept]
- 15R-methyl prostaglandin D2 [MeSH Supplementary Concept]
- 9-deoxy-9,10-didehydro-12,13-didehydro-13,14-dihydroprostaglandin D2 [MeSH Supplementary Concept]
- 9-deoxy-9,10-didehydro-12,13-didehydro-13,14-dihydroprostaglandin D2 [MeSH Supplementary Concept]
- 9-deoxy-delta-9-prostaglandin D2 [MeSH Supplementary Concept]
- NEPP11 compound [MeSH Supplementary Concept]
- TS-002 [MeSH Supplementary Concept]
- anhydrolevulgandin D2 [MeSH Supplementary Concept]
- delta(12)-prostaglandin J(2) [MeSH Supplementary Concept]
- levuglandin D2 [MeSH Supplementary Concept]
- prostaglandin D2 4-azidophenacyl ester [MeSH Supplementary Concept]
- prostaglandin D2 methyl ester [MeSH Supplementary Concept]
Semantic type(s)
- Biologically Active Substance [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Prostaglandin D2 [NCIt concept]
- Prostaglandin D2 [LOINC component]
- Prostaglandin PGD2 (substance) [SNOMED CT concept]
- prostaglandin pgd2 [SNOMED Notion]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients